top of page

 Medical Engineering Workshop

The US market for medical technology is the largest in the world and has considerable growth potential. Demographic development plays a major role here: the US population is constantly growing, but is also aging. More than three quarters of seniors in the United States have at least one chronic condition. In addition, widespread obesity is a significant risk factor. More than a third of adults and around a sixth of all children and adolescents are overweight. More than a third of the demand for medical technology in the USA is covered by imports.

The regulations and the approval process of the US Food and Drug Administration (FDA) can pose a challenge for medical technology manufacturers. With good advice, however, this is classified as predictable by industry experts.

 

The medical technology workshop highlights the current opportunities for German medical technology manufacturers and is intended to present possible challenges associated with entering the market.

Our speakers

Marius Balger

CEO, BIT Analytical Instruments GmbH 
 

After completing his mechanical engineering studies at the Technical University of Darmstadt, Marius Balger began his management career in 1996 as General Manager at MAN AG, responsible for the printing machine business in Asia and the Pacific. By moving to BIT Analytical Instruments, he initially took over sales as Vice President and shortly thereafter (2004) as Managing Director with overall responsibility. Since then, his focus at BIT has been on global growth, especially in the USA and China, as well as on expanding the service portfolio and the technical consolidation of the group. Today, BIT is the leading independent provider of high-quality in-vitro diagnostic analysis instruments in the international high-end OEM market.

 

 

Caroll H. Neubauer

Chairman & CEO, B. Braun of America Inc. 

Mr. Neubauer is a member of the Executive Board of the B. Braun Melsungen AG Group. He has been part of the B. Braun group of companies for more than 28 years. In 1991 he was elected to the Management Board of B. Braun Melsungen AG at the company's headquarters in Melsungen and appointed General Counsel of the B. Braun Group. In 1996 he assumed operational responsibility for the North American subgroup of B. Braun. Mr. Neubauer passed the 2nd state law examination in Baden-Württemberg after studying at the Albert Ludwigs University, Freiburg i. Br. and a Masters of Law degree from Georgetown University,  Washington, DC. He is Vice President of the German-American Chambers of Commerce and Chairman of the German-American Chamber of Commerce in New York.

Dirk and driver

Member of the Board of Management International Sales & Chief Commercial Officer, Bauerfeind AG

 

After completing his studies in business administration at the University of Applied Sciences in Ludwigshafen/Rhein, Dirk Driver worked from 1987-2001 at Knoll AG, the pharmaceutical subsidiary of BASF AG, with regional sales responsibility in the parent company for European markets, Asia/Pacific and for several years as regional managing director for Scandinavia . Following his leadership role in Abbott Scandinavia's Pharmaceuticals Division from 2001-2002, he joined the Novartis Group, where he held various global sales leadership positions from 2002-2012. He has been a member of the Management Board of Bauerfeind AG since 2013 and works in international sales and as the company's Chief Commercial Officer. 

 

moderation

Sven Langenau
Managing Director, AHK USA-Houston

 

Mr. Langenau has been working for the AHK USA in Houston since July 2013 and has been in charge of the Consulting Services department ever since. In November 2015, Mr. Langenau took over the management of the office as Managing Director.

After completing his studies to become a Dipl.-Ing. in precision engineering and electronic equipment technology in 1998, Mr. Langenau worked as a department and branch manager for global companies in the areas of product management and sales.

bottom of page